Galera Therapeutics Inc (NASDAQ:GRTX)
| 1.29 Delayed Data As of 3:59pm ET |  -0.01 / -0.77%Today’s Change | 1.15 Today|||52-Week Range 10.79 | -71.90% Year-to-Date |
Latest GRTX News | Press Releases
No recent news for Galera Therapeutics Inc.
Today’s Trading
| Previous close | 1.30 |
| Today’s open | 1.21 |
| Day’s range | 1.21 - 1.29 |
| Volume | 1,444 |
| Average volume (3 months) | 187,603 |
| Market cap | $38.9M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -4.64% |
| Earnings growth (this year) | +46.76% |
| Earnings growth (next 5 years) | +51.32% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$0.49 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$80.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
